Drug intelligence / Profile preview

Oxizen

Development stage
Unknown
Lead developer
Bal Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

Oxizen is a nutritional supplement softgel developed and marketed by Bal Pharma. It is formulated with a combination of flaxseed oil, folic acid (vitamin B9), and vitamin B12. Positioned within Bal Pharma's anti-diabetic portfolio, Oxizen is used as a supportive therapy to manage nutritional deficiencies and support overall metabolic, cardiovascular, and neurological health in patients with diabetes. Flaxseed oil provides essential omega-3 fatty acids (specifically alpha-linolenic acid) that support cardiovascular health and reduce inflammation. Folic acid and vitamin B12 are critical for red blood cell formation, DNA synthesis, and maintaining healthy nerve function, which is particularly beneficial in preventing or managing diabetic neuropathy.

Brand names
Oxizen
Other names
folic acid + vitamin B12 + flaxseed oilfolic acid + vitamin B12 + flaxseed oil softgelfolic acid, vitamin B12, and flaxseed oil softgel
02

Targets

DHFR (Dihydrofolate reductase)MTR (Methionine synthase)

Beyond the preview

Go deeper on Oxizen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxizen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call